Non-linear relationship between red blood cell distribution width and gastrointestinal bleeding risk in stroke patients: results from multi-center ICUs

Abstract

Background:

The red blood cell distribution width (RDW) is closely linked to the prognosis of multiple diseases. However, the connection between RDW and gastrointestinal bleeding (GIB) in stroke patients is not well understood. This study aimed to clarify this association.

Methods:

This retrospective study involved 11,107 hospitalized patients from 208 hospitals in the United States, admitted between January 1, 2014, and December 31, 2015. We examined clinical data from 7,512 stroke patients in the intensive care unit (ICU). Multivariate logistic regression assessed the link between RDW and in-hospital GIB in stroke patients. Generalized additive model (GAM) and smooth curve fitting (penalty spline method) were utilized to explore the non-linear relationship between RDW and GIB in stroke patients. The inflection point was calculated using a recursive algorithm, and interactions between different variables were assessed through subgroup analyses.

Results:

Among the 11,107 screened stroke patients, 7,512 were included in the primary analysis, with 190 identified as having GIB. The participants had a mean age of (61.67 ± 12.42) years, and a median RDW of 13.9%. Multiple logistic analysis revealed RDW as a risk factor for in-hospital GIB in stroke patients (OR = 1.28, 95% CI 1.21, 1.36, p < 0.05). The relationship between RDW and in-hospital GIB in stroke patients was found to be non-linear. Additionally, the inflection point of RDW was 14.0%. When RDW was ≥14.0%, there was a positive association with the risk of GIB (OR: 1.24, 95% CI: 1.16, 1.33, p < 0.0001). Conversely, when RDW was <14.0%, this association was not significant (OR: 1.02, 95% CI: 0.97–1.07, p = 0.4040).

Conclusion:

This study showed a substantial non-linear link between RDW and the risk of GIB in stroke patients. Maintaining the patient’s RDW value below 14.0% could lower the risk of in-hospital GIB.

Introduction

Gastrointestinal bleeding (GIB) is a frequent complication post-stroke, markedly increasing patient mortality (1–3). Studies show a 1.24% incidence of GIB after ischemic stroke in the United States and a 2.63% chance following hemorrhagic stroke in Japan (4, 5). In China, approximately 2.6% of hospitalized stroke patients experience GIB (5). Additionally, GIB has been associated with higher mortality risk in acute cardiovascular conditions such as Acute Coronary Syndrome (6, 7). Furthermore, GIB results in negative outcomes for stroke patients, with those suffering from ischemic stroke experiencing a 46% higher likelihood of severe disability and an 82% greater risk of in-hospital death (4). Our data indicate an 18.95% in-hospital mortality rate for stroke patients with GIB, a significantly high figure. Given the alarming link between GIB and stroke, identifying modifiable predictors of GIB, and enhancing patient outcomes are crucial.

Red blood cell distribution width (RDW) is a measurable clinical parameter routinely used to assess erythrocyte size variability and differentiate types of anemia. Over the past decade, RDW has gained attention as a predictive marker, confirmed by numerous studies. Research has shown a significant correlation between RDW and various diseases, including diabetes, chronic obstructive pulmonary disease (COPD), cardiovascular conditions, pneumonia, thromboembolism, Inflammatory Bowel Disease (IBD), and liver disorders (8–12), highlighting RDW’s prognostic value (13, 14).

Research indicates RDW is a valuable biomarker for assessing GIB status and prognosis (15). Liao et al. (16) in a retrospective study of 4,473 patients undergoing Coronary Artery Bypass Grafting (CABG) found elevated RDW levels associated with an increased risk of GIB post-CABG. Additionally, the study highlights the potential of RDW as a biomarker for assessing GIB risk following CABG surgery.

The role of RDW as an independent predictor of GIB in stroke patients remains to be further investigated. This study aims to investigate the relationship between RDW and in-hospital GIB following a stroke, and assess RDW’s predictive utility for this condition.

Methods

Data source

This study utilized data from the eICU Collaborative Research Database (eICU-CRD), a multi-center intensive care database comprising over 200,000 cases (17, 18). Electronic medical records from 208 U.S. hospitals, spanning 2014 to 2015, were compiled. The Institutional Review Board of the Massachusetts Institute of Technology (Cambridge, Massachusetts, USA) granted approval for database use. Data access and extraction were conducted by the author, Zhenhua Huang, under certification number 499395491.

Study population

Patients diagnosed with stroke, as recorded in the patient dataset, were potentially eligible. These stroke patients were classified into three groups: the ischemic stroke (IS) group, the hemorrhagic stroke (HS) group (comprising patients with subarachnoid hemorrhage and intracerebral hemorrhage), and another group. Initially, 11,107 stroke patients were included in this study. Subsequently, 2,762 patients were excluded due to missing data on factors such as age, gender, BMI, RDW. 833 were excluded due to RDW outliers. And those who experienced GIB within 24 h of admission or prior to admission were also excluded. Ultimately, the cohort comprised 7,512 stroke patients, including 2,371HS patients, 2,608 IS patients, and 2,533 patients with other stroke types. Among these, 190 patients were identified with GIB during their hospital stay (as depicted in Figure 1). When multiple measurements of RDW and other variables were taken after admission to the ICU, data from the initial measurement were utilized.

Figure 1

Variable extraction

In this study, the main outcome measured was the occurrence of in-hospital GIB of hospitalization for stroke patients. Detailed demographic data, such as age, body mass index (BMI), red blood cell count (RBC), hemoglobin (Hb), platelet count (PC), RDW, blood urea nitrogen (BUN), blood calcium, serum creatinine (Scr), gender, ethnicity, and past medical history, were gathered. Furthermore, for variables that were recorded multiple times within the first 24 h of admission, the value most strongly linked to disease severity was chosen (as shown in Table 1).

Statistical analysis

RDW was categorized into four quartiles: Q1 (11.4–13.1%), Q2 (13.2–13.8%), Q3 (13.9–14.9%), and Q4 (15.0–24.8%). Descriptive statistics were provided for continuous variables, including the mean and standard deviation for normally distributed data, medians with interquartile range (IQR) for non-normally distributed data, and for categorical variables, frequency and proportion were reported. Various statistical tests were employed to compare different RDW groups based on the distribution of the data. One-way analysis of variance was used for groups with a normal distribution, the χ2 method for categorical variables, and the Kruskal-Wallis H test for groups with a non-normal distribution. These tests were selected appropriately to accurately analyze the data and draw valid conclusions based on the diverse characteristics of the RDW groups. Logistic regression analysis was performed to explore the association between RDW and hospital-acquired GIB in stroke patients. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated for the study results using multivariable models. Three models were constructed: (i) an unadjusted model, (ii) a minimally adjusted model (Model I: adjusted for age, gender, and ethnicity), and (iii) a fully adjusted model (adjusted for gender, age, ethnicity, atrial fibrillation (AF), congestive heart failure (CHF), acute coronary syndrome (ACS), COPD, diabetes, hypertension, and cancer). Given the suspicion that binary logistic regression models might not adequately handle nonlinear relationships, we explored such relationships using generalized additive models (GAM) and smooth curve fitting (penalized spline method). If nonlinearity was detected, we initially calculated the inflection point using a recursive algorithm and then established a two-piecewise linear logistic regression model on both sides of the inflection point. The log-likelihood ratio test was employed to determine the most suitable model describing the association between RDW and GIB. Additionally, interactions between different variables were assessed through subgroup analyses. ROC curve analysis was conducted to assess the predictive capability of RDW for in-hospital GIB among stroke patients, with a significance threshold set at p < 0.05. The analysis was conducted using Empower Stats software and the R language, with statistical significance defined as a two-tailed p-value <0.05.

Results

Baseline characteristics

The participants were divided into quartiles, each defined by a range of RDW values. When comparing these quartiles to the Q1 reference group, several variables showed significant differences. In the highest quartile (Q4: RDW ≥ 15%), age, BMI, PC, BUN, and Scr were notably higher. Additionally, elevated rates of AF, CHF, ACS, COPD, and hypertension were observed in this quartile. Conversely, the proportion of males, Hb, calcium and RBC were lower in the highest quartile (all p-values <0.05). Furthermore, both hospital mortality and the incidence of GIB significantly increased in Q4 compared to Q1 (p-values <0.05) (Table 1). Figure 2 illustrates the skewed distribution of RDW, ranging from 11.4 to 24.8%, with a median level of 13.9%.

Figure 2

Factors influencing in-hospital GIB risk in stroke patients via univariate analysis

Table 2 illustrates the correlations between various factors and GIB following hospitalization for stroke patients, as analyzed through univariate analysis. Significant associations with GIB (p < 0.05) were observed for RDW, age, Scr, calcium, BUN, RBC, Hb and BUN levels. Similarly, GIB exhibited significant correlations with ACS, COPD, CHF, AF, diabetes, and hypertension rates (all p < 0.05). However, no significant associations were found between hospital-acquired GIB and BMI, PC, gender, ethnicity, or cancer rates (all p > 0.05).

RDW’s association with in-hospital GIB in univariate and multivariate analyses

In univariate analysis, a significant association was observed between continuous RDW and in-hospital GIB (OR 1.28, 95% CI (1.22, 1.35), p < 0.001). To address various risk factors, including critical clinical variables, we developed a multivariate model. RDW remained an independent predictor of in-hospital GIB in both adjusted Model II (OR 1.29, 95% CI 1.22–1.36, p < 0.001) and Model III (OR 1.28, 95% CI 1.21–1.36, p < 0.001), as shown in Table 3. Furthermore, all participants were categorized into four groups based on RDW quartiles. Using the Q1 group as a reference, a significant increase in GIB risk was observed in the highest quartile (Q4) (p < 0.001), as illustrated in Table 3.

Non-linear relationship of RDW and in-hospital GIB in stroke patients

To further explore the relationship between RDW and in-hospital GIB incidence, we generated smoothing curves using a generalized additive model, adjusting for age, gender, ethnicity, AF, CHF, ACS, COPD, diabetes, hypertension, and cancer. The results showed a nonlinear association between RDW and in-hospital GIB risk, as illustrated in Figure 3. Furthermore, the curve notably steepened in the Q4 quartile, indicating a rapid and significant increase in in-hospital GIB incidence with rising RDW, especially in the Q4 group. Segmented regression models identified a threshold RDW value of 14.0% (p < 0.001 based on the log-likelihood ratio test). RDW ≥ 14.0% was positively associated with GIB risk (OR: 1.24, 95% CI: 1.16, 1.33, p < 0.0001). Conversely, RDW < 14.0% showed no significant association with GIB risk (OR: 1.02, 95% CI: 0.97–1.07, p = 0.4040) (as demonstrated in Table 4).

Figure 3

Subgroup analyses for RDW impact on in-hospital GIB after stroke

Subgroup analyses were conducted to identify potential factors influencing RDW’s impact on in-hospital GIB post-stroke, as outlined in Table 5. Significant interactions between RDW and BUN, as well as creatinine levels, were observed regarding in-hospital GIB post-stroke. Specifically, patients with BUN levels <20 mg/dL had an elevated risk of GIB (OR = 1.37, 95% CI 1.24, 1.51), while those with creatinine levels <1.2 mg/dL also showed increased GIB risk (OR = 1.38, 95% CI 1.26, 1.50). There were no significant interactions observed between age, RBC, AF, ACS, CHF, COPD, DM, DKA, cancer, stroke type, and in-hospital GIB.

Roc curves for RDW predicting in-hospital GIB after stroke

Figure 4 and Table 6 presents the Receiver operating characteristics (ROC) curves for RDW in predicting in-hospital GIB in stroke patients among all participants. The AUC values and 95% CIs for RDW was 0.671 (0.632, 0.708). And the best threshold was 14.850.

Figure 4

Discussion

Our retrospective study indicates a positive correlation between elevated RDW levels and increased risk of GIB in stroke patients. Specifically, each unit increase in RDW was associated with a 28% higher risk of GIB. We also discovered a non-linear correlation between RDW levels and GIB risk, where levels ≥14.0% showed a significant positive correlation (OR: 1.24, 95% CI: 1.16–1.33, p < 0.0001), while levels <14.0% did not show a statistically significant correlation (OR: 1.02, 95% CI:0.97–1.07, p = 0.4040).

Recent studies consistently demonstrate a strong link between increased RDW and a range of diseases such as cancers, digestive disorders, and cardiovascular conditions (19–23). Tonelli et al. (24) found that higher RDW levels correlate with increased cardiovascular events in patients with coronary artery disease, indicating that RDW may reflect disease severity and prognosis. Felker et al. (25) noted that higher RDW levels are associated with adverse outcomes in heart failure patients, underscoring its utility as a prognostic marker. Patel et al. (26) linked higher RDW levels to increased mortality in older adults, highlighting RDW’s role as a survival predictor, useful for health and prognosis evaluations. Recent studies have explored the link between higher RDW levels and increased GIB risk. A 2017 study showed that elevated RDW levels correlate with greater upper gastrointestinal bleeding (UGIB) risk (27). Another study identified RDW as an independent predictor of GIB post-CABG (16).

In 2019, stroke was a leading global health issue, with approximately 12.2 million cases worldwide, making it the second leading cause of death (28). GIB is a serious complication following a stroke, often presenting through subtle symptoms that pose challenges in timely diagnosis. Our study investigated the non-linear relationship between RDW and in-hospital GIB in stroke patients, even when adjusting for factors like age, gender, ethnicity, and various health conditions. Our analysis revealed significant interactions between RDW and both BUN and creatinine levels in relation to in-hospital GIB. Patients with lower BUN and creatinine levels demonstrated an increased risk of GIB, suggesting that monitoring RDW values can prompt early intervention and potentially reduce GIB incidence in stroke patients.

Our study identifies a non-linear association between RDW and in-hospital GIB in stroke patients, accounting for variables such as age, gender, ethnicity, and health conditions. Using a two-piecewise linear logistic regression model, we established the inflection point for RDW. At RDW levels ≥14.0%, there was a significant positive correlation with GIB risk. Conversely, at RDW levels <14.0%, the association was not significant. Subgroup analysis explored factors influencing RDW’s impact on in-hospital GIB in stroke patients. Significant interactions between RDW and both BUN and Scr levels were noted, relating to in-hospital GIB in stroke patients. Patients with BUN below 20 mg/dL and creatinine below 1.2 mg/dL showed an increased GIB risk. Therefore, using RDW values to predict GIB risk can facilitate early intervention by healthcare providers, potentially reducing GIB incidence in stroke patients.

Our study has notable strengths. For the first time, we explored the association between RDW and GIB risk in stroke patients, utilizing data from multiple centers and a large sample size. Through comprehensive multivariable logistic regression analysis, we accounted for several variables associated with GIB risk, including age, gender, ethnicity, and medical conditions such as AF, CHF, ACS, COPD, diabetes, hypertension, and cancer. This thorough consideration of pertinent variables bolsters the credibility of our findings. Secondly, we utilized cubic spline functions and smooth curve fitting to elucidate the non-linear relationship between RDW and GIB in stroke patients. Importantly, we identified the inflection point for RDW, offering critical clinical insights for preventing GIB in stroke patients.

However, our study has certain limitations. Firstly, this analysis relies on retrospective data, which may have limitations related to data collection and potential biases. We plan to conduct prospective research in the future to address these limitations. Secondly, the presence of only short-term follow-up data in the database limited our ability to discern long-term outcomes. Additionally, this retrospective observational study provides an association inference rather than establishing a causal relationship between RDW and The risk of gastrointestinal bleeding in stroke patients. Finally, given that our study is retrospective, the original database does not include data on non-ICU stroke patients. Therefore, we could not incorporate non-ICU stroke patients in this study. These limitations should be considered when interpreting our findings.

Conclusion

Our study revealed a significant non-linear correlation between RDW and GIB risk in stroke patients. Our findings also highlight that keeping the patient’s RDW value below 14.0% may reduce the risk of in-hospital GIB in stroke patients.

References

• 1.

  Fu J . Factors affecting the occurrence of gastrointestinal bleeding in acute ischemic stroke patients. Medicine (Baltimore). (2019) 98:e16312. doi: 10.1097/MD.0000000000016312

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 2.

  O'Donnell MJ Kapral MK Fang J Saposnik G Eikelboom JW Oczkowski W et al . Gastrointestinal bleeding after acute ischemic stroke. Neurology. (2008) 71:650–5. doi: 10.1212/01.wnl.0000319689.48946.25

  • CrossRef
  • Google Scholar

• 3.

  Chen CM Hsu HC Chuang YW Chang CH Lin CH Hong CZ . Study on factors affecting the occurrence of upper gastrointestinal bleeding in elderly acute stroke patients undergoing rehabilitation. J Nutr Health Aging. (2011) 15:632–6. doi: 10.1007/s12603-011-0052-2

  • CrossRef
  • Google Scholar

• 4.

  Rumalla K Mittal MK . Gastrointestinal bleeding in acute ischemic stroke: a population-based analysis of hospitalizations in the United States. J Stroke Cerebrovasc Dis. (2016) 25:1728–35. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.044

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 5.

  Ji R Shen H Pan Y Wang P Liu G Wang Y et al . Predictive factors for gastrointestinal bleeding following hemorrhagic stroke: a hospital-based cohort study. Brain Nerve. (2018) 14:943–6. doi: 10.1186/1471-230X-14-130

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 6.

  Albeiruti R Chaudhary F Alqahtani F Kupec J Balla S Alkhouli M . Incidence, predictors, and outcomes of gastrointestinal bleeding in patients admitted with ST-elevation myocardial infarction. Am J Cardiol. (2019) 124:343–8. doi: 10.1016/j.amjcard.2019.05.008

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 7.

  al-Mallah M Bazari RN Jankowski M Hudson MP . Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes. J Thromb Thrombolysis. (2007) 23:51–5. doi: 10.1007/s11239-006-9005-8

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 8.

  Wang J Zhang Y Wan Y Fan Z Xu R . The relationship between red blood cell distribution width and incident diabetes in Chinese adults: a cohort study. J Diabetes Res. (2020) 2020:1623247–7. doi: 10.1155/2020/1623247

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 9.

  Ozgul G Seyhan EC Özgül MA Günlüoğlu MZ . Red blood cell distribution width in patients with CORonic obstructive pulmonary disease and healthy subjects. Arch Bronconeumol. (2017) 53:107–13. doi: 10.1016/j.arbres.2016.05.021

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 10.

  Conic RR Damiani G Schrom KP Ramser AE Zheng C Xu R et al . Psoriasis and psoriatic ArtORitis cardiovascular disease Endotypes identified by red blood cell distribution width and mean platelet volume. J Clin Med. (2020) 9:186. doi: 10.3390/jcm9010186

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 11.

  Febra C Spinu V Ferreira F Gil V Maio R Penque D et al . Predictive value for increased red blood cell distribution width in unprovoked acute venous TORomboembolism at the emergency department. Clin Appl TORomb Hemost. (2023) 29:1299592395. doi: 10.1177/10760296231193397

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 12.

  Akkermans MD Vreugdenhil M Hendriks DM van den Berg A Schweizer JJ van Goudoever JB et al . Iron deficiency in inflammatory bowel disease: the use of Zincprotoporphyrin and red blood cell distribution width. J Pediatr Gastroenterol Nutr. (2017) 64:949–54. doi: 10.1097/MPG.0000000000001406

  • CrossRef
  • Google Scholar

• 13.

  Bello S Fandos S Lasierra AB Mincholé E Panadero C Simon AL et al . Red blood cell distribution width RDW. and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin. Respir Med X. (2015) 109:1193–206. doi: 10.1016/j.rmed.2015.07.003

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 14.

  Hu Z Sun Y Wang Q Han Z Huang Y Liu X et al . Red blood cell distribution width is a potential prognostic index for liver disease. Clin Chem Lab Med. (2013) 51:1403–8. doi: 10.1515/cclm-2012-0704

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 15.

  Sun X Zhang Y Li J Zhang B Jia Q . Analysis of the effect of intelligent red blood cell distribution diagnosis model on the diagnosis and treatment of gastrointestinal bleeding. J Healthc Eng. (2021) 2021:5216979–10. doi: 10.1155/2021/5216979

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 16.

  Liao Y Zhang R Shi S Lin X Wang Y Wang Y et al . Red blood cell distribution width predicts gastrointestinal bleeding after coronary artery bypass grafting. BMC Cardiovasc Disord. (2022) 22:436. doi: 10.1186/s12872-022-02875-4

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 17.

  Pollard TJ Johnson A Raffa JD Celi LA Mark RG Badawi O . The eICU collaborative research database, a freely available multi-center database for critical care research. Sci Data. (2018) 5:180178. doi: 10.1038/sdata.2018.178

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 18.

  Sauer CM Dam TA Celi LA Faltys M de la Hoz MAA Adhikari L et al . Systematic review and comparison of publicly available ICU data sets-a decision guide for clinicians and data scientists. Crit Care Med. (2022) 50:e581–8. doi: 10.1097/CCM.0000000000005517

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 19.

  Montagnana M Danese E . Red cell distribution width and cancer. Ann Transl Med. (2016) 4:399. doi: 10.21037/atm.2016.10.50

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 20.

  Xu WY Yang XB Wang WQ Bai Y Long JY Lin JZ et al . Prognostic impact of the red cell distribution width in esophageal cancer patients: a systematic review and meta-analysis. World J Gastroenterol. (2018) 24:2120–9. doi: 10.3748/wjg.v24.i19.2120

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 21.

  Aslam H Oza F Ahmed K Kopel J Aloysius MM Ali A et al . The role of red cell distribution width as a prognostic marker in CORonic liver disease: a literature review. Int J Mol Sci. (2023) 24:487. doi: 10.3390/ijms24043487

  • CrossRef
  • Google Scholar

• 22.

  Parizadeh SM Jafarzadeh-Esfehani R Bahreyni A Ghandehari M Shafiee M Rahmani F et al . The diagnostic and prognostic value of red cell distribution width in cardiovascular disease; current status and prospective. Biofactors. (2019) 45:507–16. doi: 10.1002/biof.1518

  • CrossRef
  • Google Scholar

• 23.

  Alcaíno H Pozo J Pavez M Toledo H . Red cell distribution width as a risk marker in patients with cardiovascular diseases. Rev Med Chile. (2016) 144:634–42. doi: 10.4067/S0034-98872016000500012

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 24.

  Tonelli M Sacks F Arnold M Moye L Davis B Pfeffer M et al . Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. (2008) 117:163–8. doi: 10.1161/CIRCULATIONAHA.107.727545

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 25.

  Felker GM Allen LA Pocock SJ Shaw LK McMurray J Pfeffer MA et al . Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM program and the Duke databank. J Am Coll Cardiol. (2007) 50:40–7. doi: 10.1016/j.jacc.2007.02.067

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 26.

  Patel KV Semba RD Ferrucci L Newman AB Fried LP Wallace RB et al . Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci. (2010) 65:258–65. doi: 10.1093/gerona/glp163

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 27.

  Lee KR Park SO Kim SY Hong DY Kim JW Baek KJ et al . Red cell distribution width as a novel marker for predicting high-risk from upper gastro-intestinal bleeding patients. PLoS One. (2017) 12:e187158:e0187158. doi: 10.1371/journal.pone.0187158

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 28.

  Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. (2021) 20:795–820. doi: 10.1016/S1474-4422(21)00252-0

  • Pubmed Abstract
  • CrossRef
  • Google Scholar